We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Cemex
CX
$16.1B
| $9.5M | 0.02% |
2,422,759
+1,741,215
| +255% | +$7.47M |
|
677
Western Alliance Bancorporation
WAL
$8.91B
| $9.41M | 0.02% |
135,924
-14,070
| -9% | -$1.08M |
|
|
AIRC
678
DELISTED
Apartment Income REIT Corp.
AIRC
| $9.4M | 0.02% |
227,923
+181,793
| +394% | +$8.43M |
|
679
Jones Lang LaSalle
JLL
$16.7B
| $9.31M | 0.02% |
54,081
+4,411
| +9% | +$879K |
|
680
TD Synnex
SNX
$20.4B
| $9.29M | 0.02% |
103,339
-189,489
| -65% | -$18.8M |
|
681
Ingevity
NGVT
$2.68B
| $9.28M | 0.02% |
149,616
-17,023
| -10% | -$1.11M |
|
682
Ubiquiti
UI
$34.9B
| $9.26M | 0.02% |
37,402
-4,688
| -11% | -$1.25M |
|
683
BorgWarner
BWA
$14.1B
| $9.23M | 0.02% |
316,753
+242,923
| +329% | +$8M |
|
684
Cooper Companies
COO
$15B
| $9.18M | 0.02% |
117,252
-120,140
| -51% | -$10.6M |
|
|
ITOS
685
DELISTED
iTeos Therapeutics
ITOS
| $9.17M | 0.02% |
445,110
+327,025
| +277% | +$7.76M |
|
686
Lincoln Electric
LECO
$15.6B
| $9.04M | 0.02% |
74,169
+13,617
| +22% | +$1.79M |
|
687
Brown & Brown
BRO
$24B
| $8.98M | 0.02% |
155,409
+65,876
| +74% | +$4.04M |
|
688
ICICI Bank
IBN
$108B
| $8.86M | 0.02% |
499,495
+42,990
| +9% | +$804K |
|
689
Omega Healthcare
OHI
$14B
| $8.77M | 0.02% |
311,167
-263,371
| -46% | -$7.5M |
|
690
Fastenal
FAST
$60.3B
| $8.62M | 0.02% |
349,390
-1,033,764
| -75% | -$27.9M |
|
691
Digital Turbine
APPS
$1.62B
| $8.61M | 0.02% |
506,645
+376,668
| +290% | +$10.2M |
|
692
Post Holdings
POST
$3.56B
| $8.59M | 0.02% |
104,327
+77,613
| +291% | +$6.02M |
|
693
CrowdStrike
CRWD
$226B
| $8.58M | 0.02% |
207,100
-135,268
| -40% | -$6.12M |
|
694
Avis
CAR
$4.99B
| $8.55M | 0.02% |
59,158
+29,469
| +99% | +$6.46M |
|
695
Howmet Aerospace
HWM
$113B
| $8.49M | 0.02% |
276,878
-57,730
| -17% | -$1.98M |
|
696
PG&E
PCG
$37.7B
| $8.47M | 0.02% |
864,212
+763,050
| +754% | +$8.97M |
|
697
Warrior Met Coal
HCC
$5.08B
| $8.46M | 0.02% |
276,423
+188,791
| +215% | +$6.54M |
|
698
DuPont de Nemours
DD
$19.4B
| $8.46M | 0.02% |
122,767
-262,260
| -68% | -$21.5M |
|
699
BOK Financial
BOKF
$8.76B
| $8.42M | 0.02% |
113,657
-49,765
| -30% | -$4.2M |
|
700
Rockwell Automation
ROK
$49.6B
| $8.31M | 0.02% |
42,425
-79,720
| -65% | -$18M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.